Ms. Margarita Paláu-Hernández will be appointed to the board of directors of the Company (the “Board”) to fill a vacancy, effective as of June 3, 2024.
On May 29, 2024, Jeryl Hilleman notified the Board of Directors (the “Board”) of Minerva Neurosciences, Inc. (the “Company”) of her intention to resign as a member of the Board, effective August 6, 2024, including from her role as Chair of the Audit Committee of the Board.
On and effective as of May 25, 2024, the Board of Directors (the “ Board ”) of the Company approved the expansion of the size of the Board from seven to eight and appointed James Beer as a Class III director of the Company
On May 29, 2024, the Board, upon the recommendation of its Nominating and Corporate Governance Committee, elected Simon Patterson as a Class II director, effective immediately, to fill the vacancy on the Board created by the resignation of Adam Karol.
Thomas J. Hansen, who served as a director of Terex Corporation (the “Company”) since 2008, did not stand for reelection at the Company’s 2024 Annual Meeting and therefore retired as a member of the Board of Directors effective May 23, 2024.
On May 29, 2024, the holders of Class B common stock of Simon Property Group, Inc. (the “Company”), acting by written consent, voted to elect Eli Simon to the Company’s Board of directors to serve as a Class B director.
On May 22, 2024, the Board of Directors (the “Board”) of First Capital, Inc. (the “Company”) accepted the resignation of Michael L. Shireman from the Board.
Following the voting on Proposal 1 (as listed below in Item 5.07) at the Annual Meeting on May 23, 2024, Roger Stoll's previously announced retirement from the Board took effect.
On May 22, 2024, Marius A. Haas informed Westlake Corporation (the “Company”) of his decision to resign from the Board of Directors of the Company in order to focus on BayPine Capital, a private equity investment company of which he is a founding partner.
Departed
Nicholas Parker
Director
Clean Energy Special Situations Corp.
Effective
2024-05-23
Filed
May 29, 2024, 7:59 PM ET
On May 23, 2024, the board of directors of the Company (the “ Board ”) accepted the resignation of Nicholas Parker as a member of the Board and all committees thereof, effective as of May 23, 2024.
On May 23, 2024, the Board of Directors of Coda Octopus Group, Inc. (the “Company”) elected Dr. Angus McFadzean as a director of the Company, effective July 1, 2024.
In accordance with the ONE Gas, Inc. (the “Company”) director retirement policy as set forth our By-Laws and Corporate Governance Guidelines, Robert B. Evans and Douglas H. Yaeger retired from the Board of Directors effective May 23, 2024, immediately prior to the annual meeting of shareholders.
In accordance with the ONE Gas, Inc. (the “Company”) director retirement policy as set forth our By-Laws and Corporate Governance Guidelines, Robert B. Evans and Douglas H. Yaeger retired from the Board of Directors effective May 23, 2024, immediately prior to the annual meeting of shareholders.
On May 23, 2024, Andrew Lapham notified the Board of Directors (the “Board”) of Loop Industries, Inc. (the “Company”) that he plans to retire and not stand for re-election as director at the Company’s Annual Meeting of Stockholders to be held on June 28, 2024 (the “Annual Meeting”).
On and effective May 24, 2024, the Board of Directors (the “Board”) of Zentalis Pharmaceuticals, Inc. (the “Company”) increased its size from six to seven directors and appointed Luke Walker, M.D., as a Class II director.
On May 23, 2024, Robert Enslin informed UiPath, Inc. (the “Company”) of his resignation from the Board of Directors of the Company (the “Board”) and from his position as Chief Executive Officer (“CEO”) of the Company, effective June 1, 2024
the board of directors (the “Board”) of Apogee Therapeutics, Inc. (the “Company”) elected Lisa L. Bollinger, M.D. to serve as a Class II director of the Company
the Board of the Company increased its size from eight to ten directors and appointed (i) Mr. Jellison to the Board as a Class I director, with a term expiring at 2024 Annual Meeting and (ii) Mr. Capper to the Board as a Class II director, with a term expiring at the Company’s 2025 annual meeting of stockholders.
the Board of the Company increased its size from eight to ten directors and appointed (i) Mr. Jellison to the Board as a Class I director, with a term expiring at 2024 Annual Meeting and (ii) Mr. Capper to the Board as a Class II director, with a term expiring at the Company’s 2025 annual meeting of stockholders.
Departed
Dr. Shih-Yin Ho
Director
Veradigm Inc.
Effective
2024-06-07
Filed
May 28, 2024, 7:59 PM ET
Dr. Ho informed the Board of Directors of the Company (the “Board”) of her decision to resign as a director of the Company, effective upon the expiration of Dr. Ho’s term of service on the Initial Term Date.
effective as of the Transition Date, Dr. Gano has been appointed to the Board as a Class II director to serve until Neurocrine’s 2025 annual meeting of stockholders.
Further, on the Effective Date, the Board appointed Kui Jiang to the Board and to serve as Chairman of the Nominating and Corporate Governance Committee and a member of the Compensation Committee.
On May 24, 2024, upon the recommendation of its Nominating and Corporate Governance Committee, the board of directors (the “Board”) of SiriusPoint Ltd. (the “Company”), increased the size of the Board from nine to ten members, and appointed Susan Cross to fill the newly created vacancy, to serve as a Class I director
Departed
Carole Faig
Director
Cue Health Inc.
Effective
2024-05-28
Filed
May 28, 2024, 7:59 PM ET
On May 24, 2024, each of the members of the Company’s board of directors, Chris Achar, Joanne Bradford, Carole Faig, Josh Ghaim, Sachin Jain and Maria Martinez (together, the “Remaining Directors”), provided notice of his or her resignation from the Board and all committees thereof, effective upon the Company’s submission of the Petition.
Departed
Josh Ghaim
Director
Cue Health Inc.
Effective
2024-05-28
Filed
May 28, 2024, 7:59 PM ET
On May 24, 2024, each of the members of the Company’s board of directors, Chris Achar, Joanne Bradford, Carole Faig, Josh Ghaim, Sachin Jain and Maria Martinez (together, the “Remaining Directors”), provided notice of his or her resignation from the Board and all committees thereof, effective upon the Company’s submission of the Petition.
Departed
Maria Martinez
Director
Cue Health Inc.
Effective
2024-05-28
Filed
May 28, 2024, 7:59 PM ET
On May 24, 2024, each of the members of the Company’s board of directors, Chris Achar, Joanne Bradford, Carole Faig, Josh Ghaim, Sachin Jain and Maria Martinez (together, the “Remaining Directors”), provided notice of his or her resignation from the Board and all committees thereof, effective upon the Company’s submission of the Petition.
Departed
Joanne Bradford
Director
Cue Health Inc.
Effective
2024-05-28
Filed
May 28, 2024, 7:59 PM ET
On May 24, 2024, each of the members of the Company’s board of directors, Chris Achar, Joanne Bradford, Carole Faig, Josh Ghaim, Sachin Jain and Maria Martinez (together, the “Remaining Directors”), provided notice of his or her resignation from the Board and all committees thereof, effective upon the Company’s submission of the Petition.
Departed
Sachin Jain
Director
Cue Health Inc.
Effective
2024-05-28
Filed
May 28, 2024, 7:59 PM ET
On May 24, 2024, each of the members of the Company’s board of directors, Chris Achar, Joanne Bradford, Carole Faig, Josh Ghaim, Sachin Jain and Maria Martinez (together, the “Remaining Directors”), provided notice of his or her resignation from the Board and all committees thereof, effective upon the Company’s submission of the Petition.
Departed
Christopher Kochuba
Director
Applied UV, Inc.
Effective
2024-05-21
Filed
May 28, 2024, 7:59 PM ET
On May 21, 2024, the Company accepted the resignation of Christopher Kochuba as a member of the following: (i) the Board of Directors of the Company (“Board”); (ii) the audit committee of the Board (the “Audit Committee”); and (iii) the Compensation Committee of the Board (the “Compensation Committee”), effective as of May 21, 2024.
Departed
Joseph Luhukay
Director
Applied UV, Inc.
Effective
2024-05-24
Filed
May 28, 2024, 7:59 PM ET
On May 24, 2024, the Company accepted the resignation of Joseph Luhukay as a member of the following: (i) the Board; (ii) the Audit Committee; (iii) the Compensation Committee; and (iv) the Nominating and Corporate Governance Committee, effective as of May 24, 2024.
Peter Howell, who retired from the Board effective May 22, 2024.
Departed
Nils Michaelis
Director
Aura Fat Projects Acquisition Corp
Effective
2024-05-04
Filed
May 28, 2024, 7:59 PM ET
On May 4, 2024, Nils Michaelis resigned from the board of directors of the Company, for personal reasons
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.